Nektar Therapeutics (NKTR US)

Analysis

Health Care • United States

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.

Refresh

Company Presentation • 01 Oct 2026 20:00

Study update

Company Presentation • 20 Apr 2026 20:00

Study update

Company Presentation • 11 Jan 2024 09:15

J.P. Morgan 42nd Annual Healthcare Conference 2024

Company Presentation • 10 Feb 2026 21:00

Study result

Company Presentation • 16 Dec 2025 21:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Study update

Study update

J.P. Morgan 42nd Annual Healthcare Conference 2024

Study result

Study Result